Company SyntekaBio, Inc.

Equities

A226330

KR7226330009

Software

End-of-day quote Korea S.E. 06:00:00 2024-05-08 pm EDT 5-day change 1st Jan Change
10,180 KRW +0.10% Intraday chart for SyntekaBio, Inc. -0.20% -28.51%

Business Summary

Syntekabio,Inc. is a Korea-based company principally engaged in the provision of database and software. The Company develops and sells software such as personal algorithm dielectric map platform (PMAP) using artificial intelligence (AI) technology, provides clinical trial modeling and genome analysis services through big data. The analysis results are used to diagnose genetic diseases, select biomarker treatments and predict disease risk. In addition, the Company develops AI drug development technology, provides research services for candidate substances of immuno-cancer drugs.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Genome Analysis
100.0 %
244 100.0 % 123 100.0 % -49.42%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
244 100.0 % 123 100.0 % -49.42%

Managers

Managers TitleAgeSince
Chief Executive Officer - 14-12-31
Founder - 08-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Sales & Marketing - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,258,475 12,238,570 ( 80.21 %) 0 80.21 %

Shareholders

NameEquities%Valuation
2,465,895 16.16 % 20 M ₩
79,450 0.5207 % 660 387 ₩
74,002 0.4850 % 615 103 ₩
66,600 0.4365 % 553 578 ₩
Sook Kim
0.1917 %
29,250 0.1917 % 243 125 ₩
18,000 0.1180 % 149 616 ₩
14,000 0.0918 % 116 368 ₩
14,000 0.0918 % 116 368 ₩
Hyundai Asset Management Co., Ltd.
0.0592 %
9,040 0.0592 % 75 140 ₩

Company contact information

Syntekabio, Inc

512, Techno World 2 No. 187, Techno World

34-000, Daejeon

+

http://www.syntekabio.com
address SyntekaBio, Inc.(A226330)
  1. Stock Market
  2. Equities
  3. A226330 Stock
  4. Company SyntekaBio, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW